Validation and real-world assessment of the Functional Assessment of Anorexia-Cachexia Therapy (FAACT) scale in patients with advanced non-small cell lung cancer and the cancer anorexia-cachexia syndrome (CACS)
- 14 January 2015
- journal article
- research article
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 23 (8) , 2341-2347
Abstract
Patients with cancer anorexia-cachexia syndrome (CACS) suffer a significant symptom burden, impaired quality of life (QoL), and shorter survival. Measurement of QoL impairments related to CACS is thereby important both in clinical practice and in research. We aimed to further validate the Functional Assessment of Anorexia-Cachexia Therapy (FAACT) scale in an advanced lung cancer population. We tested the performance of the FAACT and its anorexia-cachexia subscale (ACS) within a dataset of patients with advanced non-small cell lung cancer (aNSCLC), using standard statistical methods. We then compared the performance of commonly used QoL measures stratified by CACS status and by patient self-report of appetite and weight loss. The FAACT and its ACS demonstrate internal validity consistent with acceptable published ranges for other QoL scales (Cronbach alpha = 0.9 and 0.79, respectively). Correlation coefficients demonstrate moderate correlations in the expected directions between FAACT and ACS and scales that measure related constructs. Comparing patients with and without CACS, the ACS is more sensitive to change than other QoL instruments (mean score 33.1 vs. 37.2, p = 0.011, ES = 0.58). In patients with aNSCLC, the FAACT and its ACS performed well compared with other instruments, further supporting their validity and value in clinical research. FAACT and ACS scores covaried with symptoms and other QoL changes that are typical hallmarks of CACS, lending further support to their use as QoL endpoints in clinical trials among patients with CACS.Keywords
This publication has 15 references indexed in Scilit:
- A systematic review of health-related quality of life instruments in patients with cancer cachexiaSupportive Care in Cancer, 2013
- Longitudinal Patient-Reported Performance Status Assessment in the Cancer Clinic Is Feasible and PrognosticJournal of Oncology Practice, 2011
- Definition and classification of cancer cachexia: an international consensusThe Lancet Oncology, 2011
- Need for Mechanistically Focused Research of Global Systemic Interventions in Palliative CareJournal of Pain and Symptom Management, 2010
- Cachexia: A new definitionClinical Nutrition, 2008
- Cancer cachexia syndrome in head and neck cancer patients: Part II. PathophysiologyHead & Neck, 2007
- Cancer cachexia syndrome in head and neck cancer patients: Part I. Diagnosis, impact on quality of life and survival, and treatmentHead & Neck, 2007
- Quality of Life in Lung Cancer: The Validity and Cross-Cultural Applicability of the Functional Assessment of Cancer Therapy–Lung ScaleHematology/Oncology Clinics of North America, 2005
- Reliability and validity of the functional assessment of cancer therapy—lung (FACT-L) quality of life instrumentLung Cancer, 1995
- Quality of Life in Cancer: Definition, Purpose, and Method of MeasurementCancer Investigation, 1993